THE TRUTH ABOUT: Nm - Caught on Camera

SOAK at the baths, punk at the museum: Newcastle, are you ready to rock?

The soundtrack to New Annual 2026 tells a story about a city and its people.

Newcastle Herald · Sep 19

Nexus Mods acquires SteamDB after 13 years of solo dev work — promises no ads, no paywalls, and smarter mod-update tracking

Nexus Mods takes in SteamDB under its wing — new owners promise site will remain ad-free and non-paywalled

Tom’s Hardware · Sep 3

US judge indicates deportations to South Sudan likely violated court order

Judge Brian Murphy indicated the Trump administration’s actions to deport migrants to South Sudan ‘may be contempt’.

Al Jazeera · May 20, 2025

The Ballot Bulletin: Ballotpedia’s Weekly Digest on Election Administration, March 17, 2023

Welcome to The Ballot Bulletin: Ballotpedia’s Weekly Digest on Election Administration. Every Friday, we deliver the latest updates on election policy around the country, including legislative activity, big-picture trends, and recent news.

Ballotpedia · Mar 17, 2023

Hall Pass: Your Ticket to Understanding School Board Politics, Edition #38

Welcome to Hall Pass, a newsletter written to keep you plugged into the conversations driving school board politics and governance.

Ballotpedia · Nov 23, 2022

Pro-Russia Soldiers Fire Rocket Launchers At Enemy Targets On Leafy Lane

This is the moment pro-Russian troops load up their rocket launchers on a leafy lane and fire on enemy targets as the ‘special military operation’ enters its 98th day.

Zenger · Jun 2, 2022

Navios Maritime Stock Slips Post Q1 Results

Navios Maritime Holdings Inc. (NYSE:NM) reported first-quarter revenue growth of 9.3% year-over-year to $127.79 million. Adjusted EPS improved to $0.62 from $(0.50) in 1Q21. Time Charter Equivalent (TCE) for the quarter was $21,767 per day compared to $14,404 per day in 1Q21. Navios Maritime generated cash from operating activities in Q1 of…

Benzinga · May 19, 2022

Novamind To Host MindMed Phase IIb Trial For LSD Based Drug For Anxiety Treatment

Novamind Inc. (OTCQB:NVMDF) (CSE:NM) (FSE:HN2) has been selected by Mind Medicine, Inc. (NASDAQ:MNMD) (NEO:MMED) to host a Phase IIb randomized clinical trial investigating lysergic acid diethylamide (LSD) for generalized anxiety disorder in adults.

Benzinga · Mar 16, 2022

Novamind Stock Slightly Up On Grants Restricted Share Units

Novamind Inc. (OTCQB:NVMDF)(CSE:NM)(FSE:HN2) a mental health company specialized in psychedelic medicine, has granted an aggregate of 325,000 restricted share units effective March 11, 2022, to certain executives and employees of the company pursuant to its restricted share unit plan. The RSUs will vest in 25% intervals, every 6 months from…

Benzinga · Mar 11, 2022

Novamind To Conduct Phase II Psilocybin Trial For Major Depressive Disorder

Novamind Inc. (OTCQB:NVMDF) (CSE:NM)(FSE:HN2) will conduct a phase II clinical trial investigating psilocybin for major depressive disorder sponsored by the Usona Institute. The company completed first patient randomization at its Draper, Utah research site.

Benzinga · Mar 9, 2022